Crystal Phend
MedPage Today
Orlando, FL, United States
Contact Crystal
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Crystal:
USPSTF to Recommend Anxiety, Depression Screening
There's just one big exclusion in draft recommendations for adults → Read More
CDC Details Deadly Aromatherapy Outbreak
Tropical disease hit middle America and could pop up again, agency scientists say → Read More
FDA Gives First Greenlight to E-Cig
New approval pathway used for the first time for an ENDS device → Read More
JAMA retracts controversial masks study
A controversial study suggesting that masks may harm children by exposing them to high carbon dioxide levels was retracted. → Read More
Farxiga Gets FDA Greenlight for CKD
SGLT2 OK'd to prevent chronic kidney disease progression and cardiovascular risks → Read More
CT Useless for COVID-19 Diagnosis, Study Affirms
Even AI couldn't tell flu pneumonia from COVID in chest scans → Read More
HCQ-Arrhythmia Link Bolstered by Global Adverse Event Data
More than 8% of ventricular tachycardia reports ended in death → Read More
Kawasaki Disease From COVID-19 in Kids: How Common?
Warnings out on inflammatory syndrome but many questions remain → Read More
Hypertension Drugs Appear Safe in COVID-19
Three large observational studies add to support for continued use → Read More
ACC Meeting Cancelled
Virtual presentation plans underway, American College of Cardiology says → Read More
Burst Balloons Force TAVR Device Recall
Delivery system problems take down the latest Sapien device → Read More
First Cardiac MRI Contrast Agent Approved
FDA approved gadobutrol (Gadavist) as the first contrast agent for cardiac MRI, manufacturer Bayer announced. The gadolinium-based injection is indicated to assess myocardial perfusion and late gadolinium enhancement in adults with known or suspected coronary artery disease (CAD). Approval was based primarily on two open-label but blinded-read phase III studies in adults with CAD suspected or… → Read More
Gene Therapy Cures 'Bubble-Boy Disease'
Early trial in SCID infants showed full immune restoration → Read More
'Widowmaker' Heart Attack Tx Approved
The FDA approved SuperSaturated Oxygen (SSO2) therapy to reduce cardiac infarct size in left anterior descending ST-elevation myocardial infarction (LAD STEMI, sometimes called "the widowmaker") within 6 hours of symptom onset, TherOx announced. The company called it the first treatment other than percutaneous coronary intervention (PCI) to significantly reduce heart attack muscle damage. TherOx… → Read More
Low-Risk TAVR in Spotlight at ACC
Prevention guidelines, Apple Watch also on parade in New Orleans → Read More
FDA: Gout Drug Raises Death Risk
The FDA concluded its months-long investigation into mortality risk with febuxostat (Uloric) by mandating strong warnings on the product label and restricting use. Approved use is now only after maximally titrated allopurinol (Zyloprim) fails or isn't tolerated. Febuxostat will have to carry a black-box warning of increased risk of all-cause mortality compared with allopurinol, as had been shown… → Read More
Year in Review: Cardiology
New guidelines, PCSK9s, fish oil, TAVR, MitraClip, and aspirin → Read More
Exercise Guideline Update Gets Mostly Positive Reviews
HHS recommendations now encourage even brief activity → Read More
AHA: CABG Still Better for Multivessel Disease in Diabetes
FREEDOM trial extension suggests lower long-term mortality vs stents → Read More
Obesity in Toddlerhood Hard to Shake
Ages 2 to 6 is crucial window for BMI in youth, longitudinal study shows → Read More